Coagulation
A unique portfolio of products to assist with the identification of deficiencies in clotting factors and detection of antibodies involved in thrombosis and thrombocytopenia, providing support for the diagnosis of Heparin-Induced Thrombocytopenia (HIT) and Thrombotic Thrombocytopenic Purpura (TTP).
Explore Our Products
ATS-13® Activity Assay
What is your testing algorithm for patients suspected of having thrombotic thrombocytopenic purpura (TTP)?
PF4 Enhanced® and PF4 IgG Assay
Detect harmful antibodies that cause Heparin Induced Thrombocytopenia (HIT).
Labs We Serve
A leader in transfusion and transplantation diagnostics, Werfen is proud to partner with thousands of hospitals, clinical laboratories, reference laboratories and donor centers across the globe. Since 1982, we have been innovating on behalf of our customers, laboratories just like yours.
Select your lab type:
Upcoming Events,
Webinars & Workshops
Keep Up With Us
News & Blogs
Werfen acquires Omixon
Werfen has completed the acquisition of Omixon, a privately held company based in Budapest, Hungary, focused on the development and commercialization of Next Generation Sequencing (NGS) technologies in transplant diagnostics. The acquisition expands Werfen’s portfolio of transplant diagnostics solutions for...
News & Blogs
NEW and Definitely Improved!
You deserve exceptional service/support and our NEW Customer Center is a testament to our commitment...
News & Blogs
Werfen Completes Acquisition of Immucor, Inc.
WERFEN COMPLETES ACQUISITION OF IMMUCOR, INC., EXPANDING LEADERSHIP IN SPECIALIZED DIAGNOSTICS Werfen announced in November...
News & Blogs
Corporate Social Responsibility
Immucor is dedicated to supporting our global and local communities and environments through the giving...
News & Blogs
CYBERSECURITY is never a destination. It is a journey we are on together.
At Immucor, we are dedicated to protecting our products and the data they contain against...
Experience Our Virtual Lab
Contact your sales representative for a personal tour.
